FDA approves diagnostic test for chikungunya, dengue, or Zika; CDC to distribute

In response to a request from the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration (FDA) Thursday issued an Emergency Use Authorization (EUA) for the Trioplex Real-time RT-PCR Assay, a diagnostic tool for Zika virus that will be distributed to qualified laboratories. The assay allows doctors to tell if an individual is currently infected with chikungunya, dengue, or Zika using ["]